Growth Metrics

Bio-Rad Laboratories (BIO-B) Net Cash Flow (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Bio-Rad Laboratories - - 309.40 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -121.72%
Dec 31, 2025 427.56%
Sep 30, 2025 118.79%
Jun 30, 2025 -485.19%
Mar 31, 2025 -48.00%
Dec 31, 2024 467.23%
Sep 30, 2024 139.80%
Jun 30, 2024 -211.99%
Mar 31, 2024 156.35%
Dec 31, 2023 -176.90%
Sep 30, 2023 180.34%
Jun 30, 2023 -339.99%
Mar 31, 2023 148.75%
Dec 31, 2022 23.96%
Sep 30, 2022 59.44%
Jun 30, 2022 -165.46%
Mar 31, 2022 182.84%
Dec 31, 2021 -393.63%
Sep 30, 2021 133.42%
Jun 30, 2021 218.79%
Mar 31, 2021 109.58%
Dec 31, 2020 -182.51%
Sep 30, 2020 39,718.07%
Jun 30, 2020 101.18%
Mar 31, 2020 -151.40%
Dec 31, 2019 742.42%
Sep 30, 2019 -111.71%
Jun 30, 2019 457.92%
Mar 31, 2019 599.47%
Dec 31, 2018 -89.56%
Sep 30, 2018 482.59%
Jun 30, 2018 -133.25%
Mar 31, 2018 -59.81%
Dec 31, 2017 452.82%
Sep 30, 2017 -55.19%
Jun 30, 2017 114.55%
Mar 31, 2017 -449.36%
Dec 31, 2016 4,317.86%
Sep 30, 2016 -94.81%
Jun 30, 2016 135.70%
Mar 31, 2016 -31.60%
Dec 31, 2015 -177.16%
Sep 30, 2015 316.40%
Jun 30, 2015 1,121.44%
Mar 31, 2015 120.02%
Dec 31, 2014 -112.23%
Sep 30, 2014 121.85%
Jun 30, 2014 -38.21%
Mar 31, 2014 -3.87%
Dec 31, 2013 143.78%
Sep 30, 2013 -1,413.54%
Jun 30, 2013 94.27%
Mar 31, 2013 -404.33%
Dec 31, 2012 200.33%
Sep 30, 2012 59.48%
Jun 30, 2012 -56.66%
Mar 31, 2012 48.96%
Dec 31, 2011 -3,465.99%
Sep 30, 2011 -108.56%
Jun 30, 2011 111.16%
Mar 31, 2011 -200.91%
Dec 31, 2010 3,023.86%
Sep 30, 2010 -35.59%
Jun 30, 2010 124.96%
Mar 31, 2010 -156.66%
Dec 31, 2009 490.44%